Sheep And Goat Pox Vaccines Market to Reach $71.37 Billion by 2029, Growing at a CAGR of 4.2%

November 12, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Sheep And Goat Pox Vaccines Industry Expected To Reach By 2029, Starting From 2025 Levels?

The sheep and goat pox vaccines market size has observed steady expansion in recent years. It is anticipated to increase from $57.79 billion in 2024 to $60.43 billion in 2025, progressing at a compound annual growth rate (CAGR) of 4.6%. The historical growth of this market can be ascribed to a rise in sheep and goat pox outbreaks, government-implemented vaccination programs, advancements in veterinary medicine, considerable mortality rates in livestock, enhanced awareness among farmers, economic losses caused by the disease, trade restrictions affecting specific areas, improved diagnostic techniques, the long-standing prevalence of the disease, and cooperative efforts among veterinary institutions.

The market for sheep and goat pox vaccines is anticipated to show consistent growth in the coming years, with its size projected to reach $71.37 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 4.2%. This expansion during the forecast period can be attributed to several factors including the rising demand for livestock products, the ongoing expansion of livestock farming, government subsidies supporting vaccines, increased investment in veterinary research, technological advancements in vaccine production, heightened awareness regarding animal health, international trade agreements, climate change affecting disease patterns, the emergence of new vaccine technologies, and economic development in emerging regions. Significant trends expected during this period include the creation of multivalent vaccines, a growing application of recombinant vaccines, an increased focus on vaccine safety, a rise in public-private partnerships, the broadening of the veterinary vaccine market, digital tracking for vaccination programs, augmented funding for animal health research, regional initiatives for disease eradication, a wider adoption of sustainable farming practices, and enhanced regulatory frameworks for vaccines.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16533&type=smp

Which Drivers Are Supporting Growth Of The Sheep And Goat Pox Vaccines Market?

The increasing demand for livestock products is anticipated to drive the expansion of the sheep and goat pox vaccines market in the future. These products encompass various goods and materials derived from domesticated animals raised in agricultural settings. Multiple factors fuel this heightened demand, including rising incomes, population expansion, urbanization, evolving health awareness, shifts in consumer tastes, globalization and trade, and economic progress. Crucially, sheep and goat pox vaccines play a vital role in protecting livestock products by averting disease epidemics and maintaining the well-being and output of sheep and goat populations. An illustrative example highlights this trend: in February 2024, data from the UK’s Department for Environment, Food, and Rural Affairs indicated a rise in red meat output, with mutton and lamb production experiencing the most significant growth at 2.9%. Additionally, domestic fish production reached a total of 4,182 million metric tons in 2022. Consequently, the expanding demand for livestock products is set to boost the growth of the sheep and goat pox vaccines market.

What Are The Major Segment Categories Driving The Sheep And Goat Pox Vaccines Market Growth?

The sheep and goat pox vaccines market covered in this report is segmented –

1) By Type: Live Attenuated Vaccines, Inactivated Vaccines, Other Types

2) By Route Of Administration: Injectable, Intranasal

3) By Application: Sheep, Goat

Subsegments:

1) By Live Attenuated Vaccines: Monovalent Live Attenuated Vaccines, Multivalent Live Attenuated Vaccines

2) By Inactivated Vaccines: Adjuvanted Inactivated Vaccines, Non-Adjuvanted Inactivated Vaccines

3) By Other Types: Recombinant Vaccines, DNA-Based Vaccines

What Key Innovation Trends Are Fueling Advancements In The Sheep And Goat Pox Vaccines Market?

Major companies operating in the sheep and goat pox vaccine market are focusing on developing innovative products such as live attenuated vaccines to enhance immune responses while minimizing side effects. Live attenuated vaccines are those that contain live viruses or bacteria that have been weakened in laboratory settings to prevent them from causing disease in healthy individuals. They stimulate a powerful immune response by mimicking a natural infection without inducing illness. For instance, in August 2022, the Indian Council of Agricultural Research, an India-based research institute, developed Lumpi-ProVacInd to combat Lumpy Skin Disease (LSD) in cattle. This vaccine is designed for prophylactic immunization, providing immunity for at least one year with a single dose containing 103.5 TCID50 of the attenuated LSD virus. It is safe for animals, induces a robust immune response, and must be stored at 4°C, requiring careful handling during transportation and use.

Who Are The Major Companies Operating In The Sheep And Goat Pox Vaccines Market?

Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Santé Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer’s Pharma Private Limited, Institute of Veterinary Biological Products

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sheep-and-goat-pox-vaccines-global-market-report

Which Region Is Projected To Lead The Sheep And Goat Pox Vaccines Market During The Forecast Period?

North America was the largest region in the sheep and goat pox vaccines market in 2024. The regions covered in the sheep and goat pox vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sheep And Goat Pox Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16533&type=smp

Browse Through More Reports Similar to the Global Sheep And Goat Pox Vaccines Market 2025, By The Business Research Company

Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Pediatric Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795